Complete FDA and NHTSA recall records dated in June 2025.
These records include useful source details for the selected month.
Nissan North America, Inc. (Nissan) is recalling certain 2021-2024 Rogue, 2019-2020 Altima, 2019-2022 Infiniti QX50, and 2022 Infiniti QX55 vehicles equipped with 3-cylinder 1.5L or…
Ford Motor Company (Ford) is recalling certain 2018-2022 Transit Connect, 2019-2020 MKZ, MKX, Edge, Continental, F-150, Nautilus, Fusion, 2019-2023 Ranger, Mustang, 2020-2021 EcoSport,…
Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.
Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.
Presence of a foreign substance: black hair found embedded in tablet.
Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was…
Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules
Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was…
Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.
Ford Motor Company (Ford) is recalling certain 2025 F-150 trucks. Contact with the engine coolant hose may chafe the engine wire harness or cause a pull out of the Powertrain Control Module…
Ford Motor Company (Ford) is recalling certain 2025 Transit, F-150, and Explorer vehicles. The connecting rod and rod bearing components may have manufacturing defects that can lead to…
Defective Container: This recall is being initiated due to a leaking unit stored horizontally.
Subpotent product: Product has cloudy appearance and tested below assay label claim for 70% Ethyl Alcohol
CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
Marketed without approved NDA/ANDA: The product has been found to be tainted with Sildenafil and Propoxyphenylsildenafil (a sildenafil analogue).
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the recommended acceptable intake limit
OOS results reported for the Dissolution (by UV) test.
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.
